Related Experiment Videos
Medulloblastoma. Treatment results
Acta Radiologica: Oncology, Radiation, Physics, Biology
|January 1, 1978
Insights
This study on medulloblastoma treatment found 3-year and 5-year survival rates of 36% and 33% respectively, with no significant difference between genders.
Area of Science:
- Neuro-oncology
- Pediatric oncology
- Radiation oncology
Background:
- Medulloblastoma is a common malignant brain tumor in children.
- Treatment typically involves surgery and radiation therapy.
- Long-term survival rates and prognostic factors require further investigation.
Purpose of the Study:
- To evaluate the survival outcomes of medulloblastoma patients treated with surgery and whole central nervous system (CNS) irradiation.
- To assess potential differences in prognosis based on age group and gender.
Main Methods:
- Retrospective analysis of 44 patients diagnosed with medulloblastoma.
- Treatment protocol included primary surgical resection followed by whole CNS irradiation.
- Survival rates were calculated at 3 and 5 years post-treatment.
Main Results:
- The overall 3-year survival rate was 36%, and the 5-year survival rate was 33%.
- For children exclusively, the 3-year survival rate was 37%, and the 5-year survival rate was 33%.
- No statistically significant difference in prognosis was observed between male and female patients.
Conclusions:
- Primary surgery followed by whole CNS irradiation yields moderate survival rates for medulloblastoma.
- Age (pediatric vs. adult) and gender do not appear to be significant prognostic indicators in this cohort.
- Further research is warranted to explore novel therapeutic strategies to improve medulloblastoma outcomes.
Abstract:
A series of 44 patients with medulloblastoma is presented. The treatment was primary operation followed by irradiation of the entire CNS. The 3-year and 5-year survival rates for children and adults together were 36 and 33 per cent, respectively, and for children alone 37 amd 33 per cent, respectively. No certain difference in the prognosis for boys and girls was found.